Difference between revisions of "Team:San Andres/Software"
| Line 675: | Line 675: | ||
} | } | ||
.gwd-div-0zj6 { | .gwd-div-0zj6 { | ||
| − | -webkit-transform: translate3d(- | + | -webkit-transform: translate3d(-8.17px, -1631.31px, 0px); |
-webkit-transform-style: preserve-3d; | -webkit-transform-style: preserve-3d; | ||
} | } | ||
Revision as of 00:54, 14 August 2015
Future Projections
If our results are the expected our future projections are the following:- Be one of the first Latin American teams at the school level in the IGEM competition.
- Disclosure to the scientific community.
- Realize workshops in academic institutions of this enteropathy with the aim of being more known in society.
- Generate the product and market it for therapeutic purposes.
Business Model
If all goes
well, we going to patenting our pill, which give us licenses which we
can sell to pharmacies and laboratories to produce the medication and
sell it to celiac patients. This would mean a social benefit and an
benefict for us.
